102 related articles for article (PubMed ID: 2262930)
1. Modulation of the estrogen receptor structure, evidence of a heterogeneity.
Toulas C; Guilbaud N; Delassus F; Bayard F; Faye JC
J Recept Res; 1990; 10(1-2):1-9. PubMed ID: 2262930
[TBL] [Abstract][Full Text] [Related]
2. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the estradiol receptor in MCF-7 human breast cancer cells in culture.
Lahooti H; Thorsen T; Aakvaag A
Mol Cell Endocrinol; 1990 Nov; 74(1):21-32. PubMed ID: 2282977
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.
Trivedi S; Piccart M; Muquardt C; Gilot N; Hadiy S; Patel D; Leclercq G
Breast Cancer Res Treat; 1996; 40(3):231-41. PubMed ID: 8883965
[TBL] [Abstract][Full Text] [Related]
5. Target size analysis of estrogen receptor in cultured intact cells: change in receptor structure between subconfluency and superconfluency in culture.
Toulas C; Beauregard G; Delassus F; Thauvette L; Potier M; Bayard F; Faye JC
Mol Cell Endocrinol; 1990 Aug; 72(2):89-94. PubMed ID: 2282975
[TBL] [Abstract][Full Text] [Related]
6. Estradiol increases phosphorylation of the 90 kDa heat shock protein not associated with estradiol receptor in MCF-7 cells in culture.
Lahooti H; Thorsen T; Aakvaag A
Mol Cell Endocrinol; 1990 Nov; 74(1):33-43. PubMed ID: 2282978
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
[TBL] [Abstract][Full Text] [Related]
11. Electrophoretic analysis of large molecular weight forms of the estrogen receptor in MCF-7 human breast cancer cells.
Gabriel BW; Danforth DN
J Steroid Biochem; 1989 Oct; 33(4A):547-55. PubMed ID: 2811364
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols.
Piccart MJ; Muquardt C; Bosman C; Pirotte P; Veenstra S; Grillo F; Leclercq G
J Natl Cancer Inst; 1991 Nov; 83(21):1553-9. PubMed ID: 1960752
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D.
Navarro D; Doreste H; Cabrera JJ; Morales M; Díaz-Chico JC; Díaz-Chico BN
Breast Cancer Res Treat; 1998 Jul; 50(2):155-66. PubMed ID: 9822220
[TBL] [Abstract][Full Text] [Related]
14. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neoplasia.
Maaroufi Y; Trivedi S; Leclercq G
Cancer Biochem Biophys; 1995 Nov; 15(2):67-78. PubMed ID: 8590437
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
16. The nature and significance of multiple isoforms of the oestrogen receptor in breast tumours.
Puddefoot JR; Baker VA; Bakkers B; Marsigliante S; Barker S; Panahy C; Goode AW; Carpenter R; Vinson GP
J Mol Endocrinol; 1993 Aug; 11(1):83-90. PubMed ID: 8240675
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment.
Leclercq G; Legros N; Piccart MJ
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):545-52. PubMed ID: 1562525
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells.
Ree AH; Landmark BF; Walaas SI; Lahooti H; Eikvar L; Eskild W; Hansson V
Endocrinology; 1991 Jul; 129(1):339-44. PubMed ID: 2055193
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
Borrás M; Hardy L; Lempereur F; el Khissiin AH; Legros N; Gol-Winkler R; Leclercq G
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):325-36. PubMed ID: 8142311
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity.
Katzenellenbogen BS; Elliston JF; Monsma FJ; Springer PA; Ziegler YS; Greene GL
Biochemistry; 1987 Apr; 26(8):2364-73. PubMed ID: 3620450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
